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Abstract
Background Cancer-associated fibroblasts (CAFs) have
been recognized as important contributors to cancer
development and progression. However, opposing evidence
has been published whether CAFs, in addition to epigenetic,
also undergo somatic genetic alterations and whether these
changes contribute to carcinogenesis and tumour progression.
Methods We combined multiparameter DNA flow cytom-
etry, flow-sorting and 6K SNP-arrays to study DNA
aneuploidy, % S-phase, loss of heterozygosity (LOH) and
copy number alterations (CNAs) in cervical cancer-
associated stromal cell fractions (n=57) from formalin-
fixed, paraffin-embedded (FFPE) samples. Tissue sections
were examined for the presence of CAFs. Microsatellite
analysis was used to confirm LOH findings.
Results Smooth muscle actin and vimentin immunohisto-
chemistry verified the presence of CAFs in all cases tested.
However, we found no evidence for DNA aneuploidy,
somatic genetic alterations in the vimentin-positive stromal
cell fractions of any samples, while high frequencies of
DNA content abnormalities (43/57) and substantial numb-
ers of CNAs and LOH were identified in the keratin-
positive epithelial cell fractions. LOH hot-spots on chro-
mosomes 3p, 4p and 6p found were confirmed by micro-
satellite analysis.
Conclusion From our study we conclude that stromal cell
fractions from cervical carcinomas are DNA diploid, have a
genotype undistinguishable from patient-matched normal
tissue and are genetically stable. Using flow cytometry and
SNP-arrays, stromal genetic changes do not seem to play a
role during cervical carcinogenesis and progression. In
addition, the stromal cell fraction of cervical carcinomas
can be used as reference allowing large retrospective
studies of archival FFPE tissues for which no normal
reference tissue is available.
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1 Introduction
A major cellular component of the stroma of epithelial
tumours is the carcinoma-associated fibroblast (CAF).
Several studies demonstrated that CAFs interact with the
tumour cells and play an important role during tumour
progression and metastatic spread, and harbour biological
characteristics distinct from normal fibroblasts of the same
organ [1, 2]. Isolates from CAFs strongly promote tumour
growth and angiogenesis through secretion of stromal cell-
derived factor 1α (SDF-1α)[ 3]. CAFs resemble myofibro-
blasts and express vimentin and α-smooth muscle actin (α-
SMA). It is proposed that CAFs originate from bone
marrow derived mesenchymal stem cells [4, 5].
Stromal epigenetic alterations can have clinical conse-
quences. In oral squamous cell carcinoma it was demon-
strated that myofibroblastic stromal SMA expression
identified a group of patients with aggressive tumours [6].
Lim and co-workers used cultured fibroblast from normal
oral mucosa, epithelial dysplastic tissue and cancerous
tissue and identified gene expression profiles that reflected
different stages of tumour progression [7]. Amongst
involvement of the TNF-α and TGF-β pathway, ACTA2,
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Furthermore, expression signatures from breast cancer
strongly associated with clinical outcome [8].
Also cervical cancer stromal cell fractions have been
studied at the expression level using micro-arrays. In
response to the progression of pre-cancerous stages of the
epithelial cell fraction from CIN I to CIN III the underlying
stromal cells alter their expression pattern [9, 10]. During
CIN III/squamous cell carcinoma transition a pro-invasive
gene signature was identified.
The studies mentioned above emphasize an important
role for stroma and CAFs particularly during tumour
development and progression, and lately reviewed by
Allen, et al. [11]. Beside epigenetic changes genetic
changes, e.g. frequent copy number alterations (CNAs),
loss of heterozygosity (LOH), have been described in CAFs
from bladder cancer, breast cancer [12, 13], colon cancer
[14] and in colitis ulcerosa [15], attributing an important
role of these altered fibroblasts during carcinogenesis and
tumour evolution.
Whether cervical cancer stroma fibroblasts also undergo
somatic genetic alterations has not been investigated and it
remains unclear whether these genetic changes, when
present, contribute to the development and sustainment of
the tumour. This implies that cervical CAFs have a normal
genotype and only undergo epigenetic alterations or that
cervical CAFs might accumulate somatic genetic alterations
dissimilar from the alterations found in the epithelial cell
fraction of cervical cancer. Knowledge on the genetic status
of cervical CAFs might have consequences for tumour
behaviour and therapy, and the general understanding of
this common type of cancer.
In the present study we investigated somatic genetic
alterations and DNA content of stromal cell fractions
derived from FFPE archival cervical carcinomas. Preceding
detection of chromosomal aberrations by 6K GoldenGate
SNP-array, a highly suitable platform for detection of
CNAs and LOH in FFPE tissues [16, 17], we used FACS
to obtain pure stromal and epithelial tumour subpopulations
[18]. Patient-matched normal endometrium was used as
reference. Through our new approach we were able to
determine DNA content, genotype and genomic status of
the stromal and the epithelial fractions in FFPE archival
cervical carcinomas in parallel.
2 Materials and methods
2.1 Tissue samples and dissociation
Cervical carcinomas were obtained from the FFPE-tissue
bank of the Department of Pathology, Leiden University
Medical Center (LUMC), Leiden, the Netherlands. Samples
were handled according to the medical ethical guidelines
described in the Code Proper Secondary Use of Human
Tissue established by the Dutch Federation of Medical
Sciences (www.federa.org).
Since detection of DNA aneuploidy by flow cytometry
amongst other factors depends on the coefficient of
variation (CV) of the G0G1 population and the percentage
of DNA aneuploid tumour cells in the sample [19], we
selected 57 samples from a large series of FFPE cervical
carcinomas showing DNA histograms with a CV of the
keratin-positive G0G1 population of 6.0% or lower, without
a priori knowledge of the ploidy status of the stromal cell
fractions.
Paraffin sections taken from all samples were H&E
stained and reviewed by a pathologist (GJF). The tumour
nodule, including the intra-tumour stroma, was marked on
the H&E section using a pencil. Preceding flow cytometric
processing, carcinoma tissue was enriched for carcinoma
and carcinoma-associated stroma by trimming the normal
epithelium and/or superfluous stromal tissue and smooth
muscle tissue using surgical knifes and the marked-up H&E
section as a guide. This way the workup of stromal cells
outside the tumour nodule was prevented.
Cell suspensions were prepared, as described in detail
elsewhere [20]. In short, from 57 plus one (example with
poorly differentiated tumour cells) cervical carcinomas and
matching lymph nodes and/or endometrium six to ten
60 μm sections from each paraffin block were taken. After
collecting the thick section, a 4 μm section was taken and
H&E stained for reviewing the presence of tumour tissue.
The thick tissue sections were processed for flow cytometry.
In short, sections were dewaxed and submerged in citrate
buffer for antigen retrieval at 80°C for 60 min. Next, sections
were dissociated using a mixture of collagenase/dispase
at 37°C. Then cells were harvested, washed, counted
and stored on ice until further use.
2.2 Immunocytochemistry of cell suspensions
Immunocytochemistry was performed as described earlier
[20], with minor modifications [21]. In short, five million
cells were incubated with 200 μl of monoclonal antibody
mixture in PBS/1% BSA/0.05% Tween 20 (PBATw)
containing anti-keratin MNF116 (Cat. # 0821, DAKO,
Glostrup, Denmark), working concentration 10 μg/ml, anti-
keratin AE1/AE3 (Cat. # MAB3412, Millipore–Chemicon,
Billerica, MA), working concentration 25 μg/ml PBATw
and anti-vimentin V9-2b (diluted 1:5) (Antibodies for
Research Applications BV, Gouda, The Netherlands,
http://www.abforresearch.nl/) overnight at 4°C. The next
day, cells were washed twice with ice-cold PBATw and
centrifuged at 750 × g for 5 min at 4°C. Then, cells were
incubated with 200 μl premixed FITC- or RPE-labelled
554 W.E. Corver et al.secondary reagents [Goat F(ab2)′ anti-mouse IgG1-FITC
and goat F(ab2)′ anti-mouse IgG2b-RPE (Southern Bio-
technology Associates, Birmingham, AL), both diluted
1:100 in PBATw.] After 30 min on ice, cells were washed
twice with ice-cold PBATw and incubated with 1,000 μl
NST DNA staining solution containing 50 μM DAPI
(Sigma Aldrich) [22]. Cells were kept at room temperature
for 30 min, followed by an overnight storage at 4°C. To
reduce unwanted cell loss, compensation controls contained
one fifth of the concentration of primary antibodies used for
labelling samples for sorting. DAPI concentration was
decreased to 10 μM.
2.3 Immunohistochemistry
Immunohistochemistry for smooth muscle actin (SMA) and
vimentin was performed on 4 μms e c t i o n sa n d
aminopropylethoxysilane-coated slides. In short, paraffin
sections were deparaffinised and rehydrated. After antigen
retrieval with citrate endogenous peroxidase was quenched
with H2O2. Next, slides were washed in PBS and were
incubatedovernight atroomtemperature witha SMA-specific
primary antibody diluted 1:80 (clone 1A4, concentration
100 μg/ml, Cat. # M0851, Dako, Glostrup, Denmark). Clone
V9 and clone 1C7 were used as diluted culture supernatant
(1:80 and 1:40) for detection of vimentin and keratin 13
expression, respectively (Cat. # 2202MVI and Cat. #
2202M1C7, EuroProxima B.V., Arnhem, the Netherlands).
After washing with PBS sections were subjected to the
standard three-step ABC method (Dako, Glostrup, Denmark).
Immune complexes were visualized with diaminobenzidine
(Sigma, St. Louis) in a Tris–HCl buffer containing H2O2.
Mayer’s hematoxylin was used for counterstaining. Brown
staining of cytoplasm indicated positivity. Slides without
primary antibody were used as a negative control.
2.4 Flow cytometry and sorting
During acquisition a gate was created to collect 20,000
keratin-positive single cell events using an LSRII (BD
Biosciences, Erembodegem, Belgium) flow cytometer,
equipped with a 21 mW 488 nm laser and a 20 mW
355 nm UV laser. A data file contained all events. The UV
355 BP 450/50-A/UV 355 BP 450/50-H vs. UV 355 BP
450/50-A pulse-processor was used to enrich for single cell
events during acquisition and analysis. Detector F,
BLUE 488 BP 530/30-A and detector E, BLUE 488
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fluorescence, respectively.
For data analysis, DNA index (DI) and coefficient of
variation (CV) calculation the WinList 6.0 and ModFit
3.2.1 software packages were used (Verity Software House,
Inc., Topsham, ME). N-color compensation was used for
post-acquisition spectral cross-talk correction according to
the manufacturer’s instructions, without the use of hyperlog
transformation or log bias.
To largely limit the effect of fragmented or damaged
nuclei generated during sample preparation on genomic
data sorting was restricted to the G0G1 vimentin-positive,
keratin-negative stromal cell fractions and the vimentin-
negative, keratin-positive tumour cell fractions. Cells were
flow-sorted using a FACSAria I flow-sorter at 40 psi (BD
Biosciences, Erembodegem, Belgium) with a 100 μm
nozzle at a frequency of approximately 52.4 kHz in purity
mode. The 488 nm and the 407 nm laser line were used for
excitation. These settings allowed us to typically flow-sort
800×10
3 cells in 5 ml FalconTM tubes. The following
detector and filter settings were used during sorting: FITC
fluorescence, detector E (BLUE 488 BP 530/30-A), RPE
fluorescence, detector D, (BLUE 488 BP 575/26-A) and
DAPI fluorescence, detector A (VIOLET 407 BP 450/50-
A). A dot plot VIOLET 407 BP 450/50-A/VIOLET 407 BP
450/50-H vs. VIOLET 407 BP 450/50-A was created to
gate out doublet and aggregates during sorting. After
sorting, cells were centrifuged at 4,000 × g for 10 min
before DNA was extracted.
2.5 DNA isolation
DNA was isolated as described using an overnight
digestion with proteinase K at 56°C [23]. DNA was
purified using the Promega Protein Precipitation solution
(Promega, Leiden, Netherlands, Cat. # A1120) according
to the manufacturer’s instructions. DNA concentrations
were determined using the Picogreen method (Invitrogen,
Leiden, The Netherlands).
2.6 SNP array analysis
SNP arrays were performed at the Leiden Genome
Technology Center (http://www.lgtc.nl) as described [16]
with minor modifications: 0.4–1.0 μg DNA was used as
input in a multi-use activation step and was subsequently
dissolved in 60 μl resuspension buffer. Genotypes and the
GCS score were extracted using Beadstudio 2.3 (Illumina,
Eindhoven, The Netherlands). Only genotypes with a GCS
over 0.5 were used to eliminate low quality calls from this
analysis. LOH within a tumour sample was determined by
comparison to the reference sample. Informative SNPs,
SNPs at which the reference sample is heterozygous, were
checked for homozygosity and LOH was indicated when
two neighbouring informative SNPs were homozygous in
the tumour sample.
The beadarraySNP package was adapted to combine
copy number profiles, allele-specific intensities and the
DNA index as described elsewhere [18].
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calculated for all informative SNPs. This value is close
to 1 when the contribution of both alleles of an SNP
to the total intensity in the tumour is similar to that of
the reference sample. The value is close to 0 when
there is no signal for either of the alleles in the tumour
(LOH). Allelic imbalances will show intermediate
values. Regions with lesser allele intensity ratio close
to 1 should have an even copy number. Next, a
segmentation procedure is applied to find genomic
regions that have the same copy number and LAIR
[17]. The copy numbers assigned to each segment are
adjusted to the measured DNA index obtained by flow
cytometry. This is used to determine the copy number of
both alleles in each genomic region referred to as the
allelic state [18].
2.7 Microsatellite analysis
Genomic DNA was taken from 12 flow-sorted carcinomas
samples that showed LOH on 3p14.2 (FHIT), 4p15.2 and/
or 6p21.3 (HLA-I) in the keratin-positive tumour fraction
by SNP-array analysis. DNA extracted from the flow-sorted
vimentin-positive, patient-matched normal endometrium
fractions was used as reference. Ten informative micro-
satellite primer pairs were selected (for primer sequences:
see Supplementary Table S1): D3S1313, D3S1234,
D3S4103, D4S1609, D4S3013, D4S1546, D6S1666,
D6S273, MOGC and D6S265 (Genome Database, http://
www.gdb.org). From each primer set the forward primer
was labelled with FAM (keratin-positive fraction) or JOE
(vimentin-positive fraction). The reverse primers were
left unlabeled. Polymerase chain reactions (PCRs) were
performed according to standard procedures (Supple-
mentary Table S1). For each PCR ten nanogram of DNA
was used as input. The fluorescent PCR products were run
using an ABI 310 automated sequencer (Applied Bio-
systems, Foster City, USA) applying filter set F. The
GeneScan™ -500 ROX™ was used as size standard
(Applied Biosystems). The results were analyzed using
the ABI prism GeneScan 3.1 program. All markers
provided interpretable results.
3 Results
3.1 Flow cytometry
Flow cytometry is a reliable method to examine clonal
expansion of cells in carcinoma samples. Based on DNA
content inferences can be made about the contribution of
different cell cycle phases and the DNA index (DI) of the
tumour cells can be calculated.
After histogram analysis the average CV of the stromal
cell fractions was 3.7% +/− 1.2%. Despite the good quality
of the DNA histograms, cell populations with an abnormal
DNA content were not detected in any of the 57 stromal cell
fractions. DNA histograms from patient-matched normal
endometriumorlymphnodeswereusedasunimodalcontrols.
CVs were 3.3% +/− 1.0% and 3.8% +/− 1.3%, respectively
and in the same range as the carcinoma-stromal cell fractions.
ByflowcytometrynoDNAaneuploidywasobservedinthese
samples either. However, technically we were able to detect
DNA aneuploidy in stromal fractions of cervical carcinomas,
as demonstrated by a rare case (sample-58) containing poorly
differentiated tumour cells (Supplementary Figure S1).
The percentage of cells in the S-phase of the tumour
stromal cells, normal endometrium and lymph nodes were
low and significantly lower (p=0.0001) than the percentage
of epithelial cells in the S-phase (14.6% +/− 8.1%)
(Table 1).
Examples of DNA histograms with low background
noise of the stromal compartments and of patient-matched
normal endometrium are shown by Fig. 1 (sample-22 and
sample-16, respectively). Using anti-keratin and anti-
vimentin antibodies the epithelial fraction (red) and the
stromal fraction (green) can be clearly separated (Fig. 1a
and e). Unimodal DNA histograms were shown after
gating on vimentin-positive cell fractions and were highly
comparable with DNA histograms obtained from patient-
matched controls in all cases. After gating on the keratin-
positive fraction a DNA aneuploid tumour population was
s h o w nw i t haD Io f0 . 9 4( F i g .1d, sample-22). The second
sample shows a DNA aneuploid population (DI = 1.91)
and a DNA pseudo-diploid population (DI = 0.99)
(Fig. 1h,s a m p l e - 1 6 ) .
In contrast, 14 (25%) of the keratin-positive epithelial
cell fractions were DNA pseudo-diploid. Forty three
samples (75%) showed a DNA aneuploid fraction. Ten
of the DNA aneuploid samples were bimodal and also
showed a second (minor) epithelial population, either
DNA pseudo-diploid or DNA aneuploid (for details see
Table 1).
3.2 Confirmation of CAFs by IHC of SMA and vimentin
To confirm the presence of CAFs in the samples, trimmed
tissue sections were stained for SMA and vimentin by
standard IHC. Figure 2 shows two examples of FFPE
cervical carcinomas (A and B). The inter-epithelial stromal
cells (S) show high SMA and high vimentin expression,
whereas the tumour cells (T) are negative. Some intra-
tumour infiltrating cells were also stained by anti-
vimentin. Twenty out of the 57 samples were selected
that showed low numbers of infiltrating cells (30% or
lower) and high numbers (>70%) of CAFs based on
556 W.E. Corver et al.Fig. 1 Examples of attempts to detect DNA content abnormalities in
the vimentin-positive, keratin-negative stromal cell fractions of FFPE
cervical carcinomas by multi-parameter DNA flow cytometry. Cells
isolated from 60 μm sections after heat-induced antigen retrieval and
enzymatic dissociation, were simultaneously labelled for keratin
(FITC), vimentin (RPE) and DNA (DAPI) and measured using an
LSRII flow cytometer. Patient-matched normal endometrium served as
a DNA diploid reference. a) cervical carcinoma with one keratin-
positive cycling population, e) cervical carcinoma with two keratin-
positive cycling populations. After gating on the vimentin-positive,
keratin-negative stromal cell fractions (s, green) unimodal DNA
histograms are shown (b, f) and no DNA aneuploidy was detectable
in these fractions, despite the good quality of the DNA histograms.
DNA histograms of the stromal cell fractions were highly comparable
with that of the endometrium (c, g) samples. In contrast, DNA
aneuploidy could be readily detected in the vimentin-negative, keratin-
positive epithelial (e) cell fractions. (d) A carcinoma keratin-positive
DNA aneuploidy population with a DI of 0.94. Note that some
keratin-positive cells also express vimentin. (h) An epithelial cell
fractions showing a bi-model DNA histogram with a DNA aneuploid
population (DI = 1.91) and a DNA pseudo-diploid population (DI =
0.99) (for LAIR analysis, see Supplementary Figure S3, sample-22E
and 22 V and sample-16E and 16 V, respectively)
Table 1 Summary of flow cytometric analysis of cervical cancer stromal cells and epithelial cells, patient-matched normal endometrium and
lymph nodes
Fraction V + stroma K + carcinoma V + endometrium V + lymph node
Number 57 57 57 16
DNA (pseudo) diploid 57 14 57 16
DNA aneuploid (1 population) 0 33 0 0
DNA aneuploid and pseudo-diploid 0 3 0 0
DNA aneuploid (2 populations) 0 7 0 0
Average% CV+/− SD 3.7 +/− 1.2 4.1 +/− 1.0 3.3 +/− 1.0 3.8 +/− 1.3
Average% S-phase +/− SD 1.4 +/− 1.8 14.6 +/− 8.5 0.1 +/− 0.3 0.6 +/− 1.0
Average% BAD +/− SD 14.1 +/− 7.7 33.4 +/− 12.3 23.3 +/− 9.3 12.1 +/− 9.1
DNA pseudo-diploid 0.95 < DI < 1.05
DNA aneuploid DI ≤ 0.95 or DI ≥ 1.05
CV = coefficient of variation
BAD = background, aggregates and debris of the DNA histogram calculated using ModFit
SD = standard deviation
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samples were initially processed for flow cytometry and
sorting.
3.3 Detection of CNAs and LOH
The G0G1 of the stromal cell fractions and the G0G1 of the
epithelial cell fractions were flow-sorted. DNAwas extracted
and used in the GoldenGate 6K SNP-array. DNA extracted
from flow-sorted vimentin-positive, keratin-negative histo-
logical tumour free patient-matched normal endometrium
served as reference. Genome-wide genomic profiles from the
flow-sorted stromal cells were compared with that of patient-
matched controls and with the keratin-positive fractions.
The genotype concordance between the cervical cancer
stromal cell fractions and the paired endometrial samples
was >99.9%. By integrating the DNA index in the analysis
true copy numbers can be estimated. This method was
recently introduced as LAIR-analysis (lesser allele intensity
ratio analysis) [18].
CNAs and LOH were not detected in any of the
cervical cancer stromal cell fractions tested (Fig. 3).
Examples of LAIR-analysis of the stromal compartments
of two DNA aneuploid cervical carcinomas (sample-7 K,
DI = 0.92) and (sample-10 K, DI = 1.97) are shown in
Fig. 3b and d (chromosomes 10–15, 21 only). In contrast,
considerable numbers of CNAs and LOH, as well as copy-
neutral LOH, were detected in the keratin-positive cell
fractions in all cases. Five examples of complete LAIR-
analysis are shown in Supplementary Figure S2.
Since no somatic genetic alterations were identified
in the stromal fractions of the selected tumours, we
processed the remaining 37. Also in these samples no
CNAs or LOH were detected (Supplementary Figure S3
shows LAIR-analysis of all stromal cell fractions and of
all patient-matched endometrium cell fractions used in
this study).
3.4 Microsatellite analysis
LAIR-analysis of the epithelial cell fractions showed that
chromosomes 3p, 4p and 6p were most often affected by
absolute LOH. Losses were found in 47.4%, 40.5% and
45.4%, of the cases, respectively. To confirm these findings
we performed microsatellite analysis using informative
markers (see Supplementary Table S1) on the flow-sorted
epithelial cell fractions as well as on the stromal cell
fractions and the normal patient-matched endometrium of
12 samples. LOH, detected in the epithelial cell fractions by
LAIR-analysis, was confirmed by microsatellite analysis in
all 12 samples tested. Figure 4 shows examples (A: sample-
10, B: sample 56 and C: sample-7, respectively) of results
obtained using markers D3S1313, D4S1546 and D6S265.
The flow-sorted epithelial cell fractions only show one allele.
Fig. 2 Smooth muscle actin and vimentin are abundantly expressed in
the stroma of cervical carcinoma. Smooth-muscle actin (SMA) and
vimentin expression in tissue sections from cervical carcinomas
showing high numbers of fibroblast neighbouring the carcinoma cells. a
A DNA pseudo-diploid squamous cell carcinoma sample stained for
smooth muscle actin (SMA) (left upper panel) and vimentin (right
upper panel). b A DNA aneuploid squamous cell carcinoma stained for
SMA (lower left panel) and vimentin (lower right panel). In addition to
vimentin these fibroblast also clearly express SMA as can be observed
by standard IHC. This demonstrates that these cells resemble
myofibroblasts (magnification 200 ×). t = tumour, s = stroma
558 W.E. Corver et al.In contrast, the tumour stromal cell fractions were identical
to the vimentin-positive cell fractions of the endometrium
and showed retention of heterozygosity for the tested loci in
all 12 cases as can be observed by presence of both alleles in
the profiles (Fig. 4, compare the stromal/endometrium
fractions with the epithelial fractions).
Fig. 3 LAIR analysis of cervical cancer stromal cells and epithelial
cells. DNA extracted from flow-sorted cervical stromal cells with high
percentage of CAFs and cervical carcinoma cells was analyzed on a
6 K SNP-array highly suitable for FFPE tissues (GoldenGate assay,
Illumina). DNA from flow-sorted vimentin-positive endometrium cells
served as a patient-matched control for genotyping. Representative
LAIR plots of chromosomes 10–15 and 21 are shown of the epithelial
cell fraction and the stromal cell fraction of two DNA aneuploid
cervical carcinomas: sample-7, DI = 0.92 and sample-10, DI = 1.97,
respectively. Many alterations were identified in the epithelial cell
fractions(seealsoSupplementaryFigureS2). A, AB or AAB (characters
in blue) represents the number of copies and the ratio between the
alleles, respectively. LOH (red dotted lines) was detected on chromo-
somes 11, 13 and 14 in both samples (a, c). Note the copy neutral LOH
on chromosomes 13 and 15 of sample-7 (a), relative to a DNA
aneuploid background with a DI of 0.92, and on chromosomes 11 and
14 of sample-10 (c), relative to a highly DNA aneuploid background
with a DI of 1.97. Allelic imbalances were detected on chromosomes
11, 14 and 15 (AAB, AAAABB and AAB, respectively) of sample-10
(c). In sample-7 (a) a segment of chromosomes 10 and 21 could be
observed that showed two or one copies while clearly showing an
imbalance (2HetL and 1HetL). This could be explained by a mixtures of
AB and AA, and AB and A, respectively. In contrast, the vimentin-
positive stromal cell fractions (b, d) of both examples show a normal
heterozygous (AB) genotype for all chromosomes and no CNAs and/or
LOH can be detected (see also Supplementary Figure S3). black arrow
(1) = segmentation line (green); black arrow (2) = heterozygous SNPs
(green horizontal bars); black arrow (3) = allelic imbalance (mixture of
green, blue and red bars); black arrow (4) = LOH (red bars); black
arrow (5) = allelic state (AB, AAB, A, etc.)
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Using a combined approach of DNA content flow-sorting
and SNP-arrays we found no evidence for somatic genetic
alterations in stromal cell fractions from cervical carcino-
mas. We clearly show for the first time that these cell
fractions are DNA diploid and hold a genotype that cannot
be discriminated from patient-matched normal endometri-
um samples. From our study it can be concluded that
somatic genetic alterations in cervical cancer tumour stroma
cells do not occur and as a result cannot contribute to
development and progression of cervical cancer.
Our findings are in contrast to several earlier studies in
tumour stroma showing high frequencies of genomic
aberrations, e.g. LOH and CNAs, in diverse types of
carcinomas [12, 24–27]. Since LOH and CNAs are
associated with DNA aneuploidy [28, 29] we should have
been able to detect small DNA aneuploid populations in the
stromal fractions using our multi-parameter flow cytometric
technique. In spite of this 57 samples were devoid of DNA
aneuploidy in the stromal cell fractions. We added a sample
containing a small fraction of poorly differentiated cells that
lost keratin expression (Supplementary Figure S1) to show
our technique is sensitive enough to pick up small
subpopulations of aneuploid cells.
To our knowledge there are only a few other reports
showing a lack of evidence of somatic genetic alterations in
tumour stroma. These studies were all performed using
microdissected stroma from fresh/frozen breast and ovarian
cancer samples [30–33]. Conversely, the earlier studies that
do show somatic genetic alterations in stroma used micro-
dissected cells from FFPE archival samples. Hence, the
somatic genetic changes found in CAFs might have been
falsely introduced by the low yields and degraded DNA
generally obtained after microdissection of formalin-fixed
samples. Indeed, low concentrations of DNA input may
cause spurious changes [34, 35]. Degraded DNA has also
been suggested as a source for errors [31, 33, 36]. However,
in the current study we clearly demonstrated that with our
preparation technique and FACS sufficient amounts of
Fig. 4 Microsatellite analysis of chromosomes 3p, 4p and 6p in flow-
sorted cervical carcinoma stromal cells and epithelial cells. Figure
shows results from two DNA aneuploid (a, b) one DNA pseudo-
diploid (c) FFPE cervical carcinoma. From sample-10, sample-56 and
sample-7 LAIR plots are shown of chromosomes 3 (a), 4 (b) and 6 (c)
demonstrating LOH of chromosomal segments. LOH on chromosome
6p is copy neutral (c). The red vertical bars represent the position of
the markers on the chromosomes. LOH, as can be observed by loss of
one of the alleles, was confirmed by microsatellite analysis using 3 to
4 markers (Supplementary Table S1) for each chromosomal segment.
In contrast, no LOH was detected in the vimentin-positive, keratin-
negative cell fractions of cervical carcinomas and patient-matched
normal endometrium. Note the complete loss of the other allele in
these samples demonstrating clonal expansion of these alterations and
pure tumour populations due to FACS
560 W.E. Corver et al.DNA can be isolated for SNP-array analysis from FFPE
tissues without the introduction of artificial LOH or copy
number changes due to low DNA yields or whole genome
amplification [37]. In addition to the high cell yields that
can be obtained after our collagenase/dispase dissociation
method of FFPE tissues, FACS can separate tumour sub
populations based on DNA index, allowing the study of
intratumour heterogeneity [18, 38, 39]. Furthermore,
restricting the sorting to the G0G1 population excludes
damaged or fragmented nuclei from the tested DNA. This
improves the quality of the genomic data generated from
SNP-arrays (see Fig. 3). We also demonstrated for the first
time that these kind of studies are possible in FFPE archival
samples using multiparameter DNA flow-sorting and SNP-
arrays. In retrospective studies typically only FFPE tissue is
available, and it is often hard to obtain paired genetically
normal tissue for comparison. FACS can overcome this
limitation, and generates patient-matched tumour and
control DNA where the handling and storage conditions
of DNA from different cell populations have been identical.
Our findings match with the general paradigm of
cervical carcinogenesis, that only the epithelial cell fraction
of cervical carcinomas harbours HPV causing cellular and
molecular alterations while the stromal cell fraction is free
of this oncogenic virus [40] .A sd e s c r i b e db yo t h e r s
epigenetic stromal changes seem to assist cervical cancer
development and progression [9, 10]. Amongst infiltrating
lymphocytes showing tumour associated cytokine/chemo-
kines repertoires, fibroblasts can be found that changed
morphology and protein expression. Smooth muscle actin
was abundantly expressed in the micro environment of the
tumour nodules (see Fig. 2) reflecting the presence of
myofibroblasts. Recent studies in oral squamous cell
carcinoma also showed high levels of SMA expression
[7], which was significantly associated with disease
mortality [6]. In a previous study from our group we
demonstrated high levels of (activated) TGF-β in cervical
cancer stroma [41]. Activated TGF-β can explain the high
expression of SMA, since this chemokine induces SMA
expression [42]. Furthermore, TGF-β is a potent inhibitor
of cell cycle progression of normal cells [43], which can
also explain the low percentage of stromal cells in S-phase
comparable to S-phases found in normal endometrium and
lymph nodes. These findings are similar to those observed
in genetically unstable oral squamous cell carcinomas of
which cultured CAFs showed less proliferative activity as
compared to other fibroblast subtypes. Simultaneously, cell
cycle-related genes were down-regulated [7]. Cancer cells
can bypass a TGF-β dependent cell cycle blockage. Indeed,
a significantly higher average S-phase (average 15%) was
found for the epithelial cell fractions. Likely, CAFs do not
proliferate locally but resemble a population of fibroblasts
which proliferated and migrated from outside the tumour
nodule and differentiated in myofibroblasts. Our observa-
tions are supported by a study into the origin of murine
CAFs showing that at least 25% of the CAFs are generated
in the bone marrow and migrate to the tumour stroma [4].
Taken together, these findings weaken the point of a local
proliferation of the tumour micro environment and clonal
outgrowth of stromal cells carrying somatic genetic changes
[12, 13, 44]. The complete loss of an allele detected by
microsatellite analysis is also hard to understand in light of
the heterogeneous composition of the tumour stroma and
microdissection as method of purification of cell popula-
tions. It can only be explained by a clonal expansion of a
cell population devoid of unaffected cells. For isolation of
DNA, tumour stroma nodules up to 5 mm distant from the
tumour nodule were selected [44, 45]. Tumour stroma is, in
addition to fibroblast and CAFs, mainly composed of
variable numbers of leukocytes. This is true not only in
cervical but also in breast, colon, ovarian carcinomas and
other types of cancer. The admixture of these (genetically
normal) cells hinders the detection of absolute LOH
resulting in measurements of allelic imbalances.
We are aware that the resolution of about 500 kb of the
GoldenGate SNP-array used in our study is quite low. It is
however sufficiently large to detect the reported whole
chromosome arm losses or changes of multiple microsatellite
markers in tumour stroma as described by other studies.
Indeed,SNP-arrayanalysisclearlyshowed(seeFig.3)t h a ta l l
epithelial cell fractions, including those identified as DNA
pseudo-diploid, harboured genetic alterations (manuscript in
preparation). Microsatellite analysis confirmed the LOH
identified using SNP-arrays at the cervical cancer hot spots
on chromosomes 3p [46–48], 4p [49, 50] and 6p [39, 46, 51]
in the epithelial cells fractions but also did not reveal genetic
alteration in any of the stromal cell populations tested. In
addition, the epithelial fractions showed DNA aneuploidy in
75% of the samples, which is comparable to a multiparam-
eter flow cytometric study using fresh/frozen samples. This
demonstrates the reliability of our technique for FFPE
samples [52].
In conclusion, we clearly show by DNA content flow
cytometry, FACS and SNP-arrays that cervical cancer
stromal cells are DNA diploid, are genetically stable and
have a genotype undistinguishable from that of patient-
matchednormalendometrium.Ourfindingsareofimportance
to the general understanding of cervical carcinogenesis.
Stromal epigenetic alterations rather than stromal genetic
alterations seem to play a role in cervical carcinogenesis.
Furthermore, reliable genotypes can be generated from flow-
sorted tumour subpopulations of a large series of FFPE
archival cervical carcinomas. In addition, the stromal com-
partmentofcervicalcarcinomascanbeusedasDNA-matched
control allowing large retrospective studies of archival FFPE
tissues for which no normal reference tissue is available.
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